Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hic2
|
ENSMUSG00000050240.8 | hypermethylated in cancer 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr16_17249370_17249521 | Hic2 | 15781 | 0.091666 | -0.46 | 2.3e-04 | Click! |
chr16_17235946_17236097 | Hic2 | 2357 | 0.147761 | 0.28 | 3.1e-02 | Click! |
chr16_17243428_17243579 | Hic2 | 9839 | 0.096955 | -0.22 | 8.7e-02 | Click! |
chr16_17253660_17253811 | Hic2 | 20071 | 0.087741 | 0.19 | 1.4e-01 | Click! |
chr16_17237891_17238042 | Hic2 | 4302 | 0.112033 | -0.18 | 1.7e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_177446374_177448525 | 13.42 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
1628 |
0.31 |
chr8_41052368_41053980 | 12.12 |
Gm16193 |
predicted gene 16193 |
64 |
0.96 |
chr9_110051810_110053856 | 12.04 |
Map4 |
microtubule-associated protein 4 |
781 |
0.54 |
chr5_36868663_36870303 | 11.72 |
Ppp2r2c |
protein phosphatase 2, regulatory subunit B, gamma |
820 |
0.55 |
chr6_114282516_114283979 | 11.23 |
Slc6a1 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
457 |
0.87 |
chr1_132541040_132543287 | 11.00 |
Cntn2 |
contactin 2 |
702 |
0.64 |
chr3_8509825_8511666 | 10.00 |
Stmn2 |
stathmin-like 2 |
1159 |
0.54 |
chr7_79501250_79502506 | 9.24 |
Mir9-3hg |
Mir9-3 host gene |
1757 |
0.18 |
chrX_101301762_101302890 | 9.13 |
Nlgn3 |
neuroligin 3 |
1852 |
0.2 |
chr14_55054119_55054818 | 8.94 |
Gm20687 |
predicted gene 20687 |
477 |
0.41 |
chr7_140080531_140082545 | 8.92 |
Caly |
calcyon neuron-specific vesicular protein |
689 |
0.48 |
chr2_178141581_178143125 | 8.78 |
Phactr3 |
phosphatase and actin regulator 3 |
420 |
0.88 |
chr15_76519928_76521866 | 8.75 |
Scrt1 |
scratch family zinc finger 1 |
1005 |
0.28 |
chr6_28828230_28829085 | 8.71 |
Lrrc4 |
leucine rich repeat containing 4 |
1688 |
0.37 |
chr18_43389837_43390467 | 8.62 |
Dpysl3 |
dihydropyrimidinase-like 3 |
3225 |
0.29 |
chr1_63309029_63310075 | 8.53 |
Gm23448 |
predicted gene, 23448 |
9169 |
0.12 |
chr7_131966504_131967699 | 8.31 |
Gpr26 |
G protein-coupled receptor 26 |
641 |
0.75 |
chr5_121008454_121009154 | 8.21 |
Rph3a |
rabphilin 3A |
262 |
0.91 |
chr3_88206822_88208169 | 8.19 |
Gm3764 |
predicted gene 3764 |
183 |
0.86 |
chr1_136132801_136134260 | 8.07 |
Kif21b |
kinesin family member 21B |
2076 |
0.19 |
chr12_3930259_3930780 | 8.03 |
Gm9088 |
predicted gene 9088 |
1521 |
0.33 |
chr5_111421306_111422790 | 7.99 |
Gm43119 |
predicted gene 43119 |
1541 |
0.35 |
chrX_170674573_170675954 | 7.97 |
Asmt |
acetylserotonin O-methyltransferase |
2619 |
0.41 |
chr3_88211471_88212561 | 7.93 |
Gm3764 |
predicted gene 3764 |
2469 |
0.11 |
chr3_80800286_80803016 | 7.87 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
928 |
0.67 |
chr11_87759834_87761999 | 7.80 |
Tspoap1 |
TSPO associated protein 1 |
329 |
0.75 |
chr11_118908287_118909561 | 7.77 |
Rbfox3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
626 |
0.73 |
chr18_86712592_86713744 | 7.76 |
Cbln2 |
cerebellin 2 precursor protein |
120 |
0.98 |
chr8_70119024_70120981 | 7.76 |
Ncan |
neurocan |
871 |
0.35 |
chr3_108153841_108154889 | 7.73 |
Gpr61 |
G protein-coupled receptor 61 |
517 |
0.6 |
chr17_28040550_28042470 | 7.58 |
Anks1 |
ankyrin repeat and SAM domain containing 1 |
227 |
0.89 |
chr5_135248496_135249658 | 7.49 |
Fzd9 |
frizzled class receptor 9 |
2153 |
0.21 |
chr8_123413418_123414506 | 7.48 |
Tubb3 |
tubulin, beta 3 class III |
2372 |
0.11 |
chr6_105678414_105679444 | 7.45 |
Cntn4 |
contactin 4 |
1154 |
0.43 |
chr2_65620767_65621991 | 7.32 |
Scn2a |
sodium channel, voltage-gated, type II, alpha |
568 |
0.82 |
chr5_38151138_38153189 | 7.29 |
Nsg1 |
neuron specific gene family member 1 |
6868 |
0.16 |
chr8_123891512_123893657 | 7.28 |
Acta1 |
actin, alpha 1, skeletal muscle |
2167 |
0.16 |
chr7_82869041_82870364 | 7.26 |
Mex3b |
mex3 RNA binding family member B |
2369 |
0.22 |
chr4_142475203_142476218 | 7.23 |
Gm13052 |
predicted gene 13052 |
129235 |
0.05 |
chr15_87544354_87545329 | 7.21 |
Tafa5 |
TAFA chemokine like family member 5 |
542 |
0.87 |
chr8_12947702_12949640 | 7.19 |
Mcf2l |
mcf.2 transforming sequence-like |
718 |
0.37 |
chr8_122751484_122752386 | 7.16 |
C230057M02Rik |
RIKEN cDNA C230057M02 gene |
390 |
0.75 |
chrX_58030987_58032527 | 7.12 |
Zic3 |
zinc finger protein of the cerebellum 3 |
747 |
0.74 |
chr10_81229656_81230911 | 7.12 |
Atcay |
ataxia, cerebellar, Cayman type |
502 |
0.53 |
chr1_173365727_173366467 | 7.11 |
Cadm3 |
cell adhesion molecule 3 |
1536 |
0.34 |
chr9_58197310_58202560 | 7.06 |
Islr2 |
immunoglobulin superfamily containing leucine-rich repeat 2 |
637 |
0.54 |
chr11_84520959_84524590 | 7.04 |
Lhx1 |
LIM homeobox protein 1 |
63 |
0.97 |
chr1_92849002_92850443 | 7.03 |
Mir149 |
microRNA 149 |
656 |
0.43 |
chr9_22050521_22051976 | 6.93 |
Elavl3 |
ELAV like RNA binding protein 3 |
762 |
0.41 |
chr3_88458101_88459325 | 6.92 |
Sema4a |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
163 |
0.88 |
chr3_89243498_89245184 | 6.82 |
Trim46 |
tripartite motif-containing 46 |
672 |
0.36 |
chr13_83715222_83716973 | 6.77 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
5284 |
0.15 |
chr10_80298461_80300404 | 6.67 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
341 |
0.69 |
chr5_116589538_116590511 | 6.63 |
Srrm4 |
serine/arginine repetitive matrix 4 |
1793 |
0.34 |
chr2_181715341_181715994 | 6.62 |
Oprl1 |
opioid receptor-like 1 |
35 |
0.95 |
chr7_79505833_79506958 | 6.58 |
Mir9-3 |
microRNA 9-3 |
1131 |
0.28 |
chr13_105444000_105445296 | 6.56 |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A |
1009 |
0.69 |
chr12_108271341_108272893 | 6.46 |
Ccdc85c |
coiled-coil domain containing 85C |
3016 |
0.24 |
chr8_109250884_109251908 | 6.39 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
1530 |
0.52 |
chr12_86989498_86990698 | 6.33 |
Zdhhc22 |
zinc finger, DHHC-type containing 22 |
332 |
0.85 |
chr5_128952013_128953618 | 6.32 |
Rimbp2 |
RIMS binding protein 2 |
218 |
0.95 |
chr10_29143400_29144848 | 6.27 |
Soga3 |
SOGA family member 3 |
65 |
0.5 |
chr5_110543976_110545228 | 6.27 |
Galnt9 |
polypeptide N-acetylgalactosaminyltransferase 9 |
247 |
0.9 |
chr10_86491670_86492273 | 6.24 |
Syn3 |
synapsin III |
74 |
0.96 |
chr1_135372451_135373569 | 6.24 |
Shisa4 |
shisa family member 4 |
440 |
0.74 |
chr2_25264308_25268001 | 6.18 |
Tprn |
taperin |
1410 |
0.14 |
chr11_115495820_115496506 | 6.13 |
Gm11694 |
predicted gene 11694 |
3139 |
0.11 |
chr13_57907102_57908323 | 6.12 |
Spock1 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 1 |
125 |
0.98 |
chr15_98949772_98950556 | 6.10 |
Gm49450 |
predicted gene, 49450 |
3387 |
0.1 |
chr4_45824847_45825701 | 6.07 |
Igfbpl1 |
insulin-like growth factor binding protein-like 1 |
1649 |
0.31 |
chr8_17532221_17533470 | 6.06 |
Csmd1 |
CUB and Sushi multiple domains 1 |
2436 |
0.46 |
chr5_24623645_24624443 | 6.00 |
Smarcd3 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 |
367 |
0.77 |
chr2_157914223_157915670 | 5.93 |
Vstm2l |
V-set and transmembrane domain containing 2-like |
293 |
0.91 |
chr17_93198991_93201483 | 5.91 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
302 |
0.89 |
chr16_60605121_60606481 | 5.90 |
Gm9017 |
predicted gene 9017 |
46 |
0.78 |
chr8_84770692_84772567 | 5.88 |
Nfix |
nuclear factor I/X |
1767 |
0.22 |
chr4_156184450_156185176 | 5.88 |
Agrn |
agrin |
1088 |
0.33 |
chr11_55607331_55608633 | 5.82 |
Glra1 |
glycine receptor, alpha 1 subunit |
161 |
0.96 |
chr14_122461803_122462503 | 5.78 |
Zic5 |
zinc finger protein of the cerebellum 5 |
2132 |
0.2 |
chr8_121730928_121732115 | 5.77 |
Jph3 |
junctophilin 3 |
954 |
0.49 |
chr4_140244024_140245271 | 5.73 |
Igsf21 |
immunoglobulin superfamily, member 21 |
2137 |
0.36 |
chr15_72546044_72547992 | 5.73 |
Kcnk9 |
potassium channel, subfamily K, member 9 |
678 |
0.75 |
chr5_98180058_98181966 | 5.69 |
Prdm8 |
PR domain containing 8 |
34 |
0.97 |
chr14_67236008_67239452 | 5.68 |
Ebf2 |
early B cell factor 2 |
3086 |
0.21 |
chr9_69758963_69761490 | 5.68 |
Foxb1 |
forkhead box B1 |
714 |
0.5 |
chr15_81936444_81938042 | 5.66 |
Csdc2 |
cold shock domain containing C2, RNA binding |
261 |
0.82 |
chr13_58809397_58810364 | 5.66 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
1189 |
0.34 |
chr12_117153278_117156362 | 5.65 |
Gm10421 |
predicted gene 10421 |
3169 |
0.37 |
chr13_58807413_58808951 | 5.58 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
99 |
0.95 |
chr7_79498955_79500626 | 5.54 |
Mir9-3hg |
Mir9-3 host gene |
236 |
0.84 |
chr14_124191809_124193012 | 5.53 |
Fgf14 |
fibroblast growth factor 14 |
492 |
0.88 |
chr9_122595045_122595971 | 5.52 |
9530059O14Rik |
RIKEN cDNA 9530059O14 gene |
23006 |
0.13 |
chr7_34675027_34676317 | 5.52 |
Gm12756 |
predicted gene 12756 |
1673 |
0.3 |
chr15_82255980_82257145 | 5.52 |
1500009C09Rik |
RIKEN cDNA 1500009C09 gene |
539 |
0.56 |
chr13_78194785_78195954 | 5.51 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
1004 |
0.42 |
chrX_143930842_143933141 | 5.49 |
Dcx |
doublecortin |
1059 |
0.64 |
chrX_143518219_143519318 | 5.46 |
Pak3 |
p21 (RAC1) activated kinase 3 |
70 |
0.98 |
chr19_47017426_47018238 | 5.43 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
2679 |
0.17 |
chr6_105676979_105678296 | 5.39 |
Cntn4 |
contactin 4 |
23 |
0.52 |
chr15_79438311_79439977 | 5.38 |
Csnk1e |
casein kinase 1, epsilon |
126 |
0.93 |
chr11_80478619_80479391 | 5.36 |
Cdk5r1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
1949 |
0.32 |
chr9_106456260_106457377 | 5.35 |
Pcbp4 |
poly(rC) binding protein 4 |
721 |
0.42 |
chrX_110814269_110815716 | 5.34 |
Pou3f4 |
POU domain, class 3, transcription factor 4 |
712 |
0.71 |
chr17_55986138_55987186 | 5.33 |
Fsd1 |
fibronectin type 3 and SPRY domain-containing protein |
147 |
0.89 |
chr2_70564530_70567543 | 5.31 |
Gad1 |
glutamate decarboxylase 1 |
341 |
0.83 |
chr3_55242295_55243824 | 5.31 |
Dclk1 |
doublecortin-like kinase 1 |
533 |
0.78 |
chr3_88214322_88216234 | 5.29 |
Mir3093 |
microRNA 3093 |
107 |
0.63 |
chr3_108410436_108412210 | 5.29 |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
4229 |
0.11 |
chr7_144898015_144898977 | 5.26 |
Gm26793 |
predicted gene, 26793 |
1035 |
0.34 |
chr1_77505286_77506951 | 5.26 |
Epha4 |
Eph receptor A4 |
8961 |
0.18 |
chr17_56241459_56242409 | 5.25 |
A230051N06Rik |
RIKEN cDNA A230051N06 gene |
218 |
0.81 |
chr17_91092075_91093120 | 5.24 |
Nrxn1 |
neurexin I |
136 |
0.95 |
chr2_25877424_25878675 | 5.23 |
Kcnt1 |
potassium channel, subfamily T, member 1 |
168 |
0.93 |
chr7_51625935_51626546 | 5.22 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
1092 |
0.52 |
chr1_42700192_42700666 | 5.20 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
4661 |
0.15 |
chr2_151969889_151971485 | 5.20 |
Fam110a |
family with sequence similarity 110, member A |
2707 |
0.18 |
chr5_30106879_30107999 | 5.20 |
3110082J24Rik |
RIKEN cDNA 3110082J24 gene |
1353 |
0.28 |
chr12_61523440_61524787 | 5.19 |
Lrfn5 |
leucine rich repeat and fibronectin type III domain containing 5 |
165 |
0.95 |
chr2_32428080_32429746 | 5.19 |
Slc25a25 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
1839 |
0.19 |
chr6_136172206_136173574 | 5.18 |
Gm26653 |
predicted gene, 26653 |
171 |
0.59 |
chr15_85576096_85578271 | 5.15 |
Wnt7b |
wingless-type MMTV integration site family, member 7B |
887 |
0.54 |
chr6_93911862_93913573 | 5.14 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
213 |
0.95 |
chr2_28195247_28196182 | 5.13 |
Olfm1 |
olfactomedin 1 |
2621 |
0.32 |
chr6_113501346_113502215 | 5.11 |
Prrt3 |
proline-rich transmembrane protein 3 |
38 |
0.94 |
chr2_27027194_27027995 | 5.10 |
Slc2a6 |
solute carrier family 2 (facilitated glucose transporter), member 6 |
315 |
0.79 |
chr13_54951042_54951756 | 5.10 |
Unc5a |
unc-5 netrin receptor A |
1988 |
0.26 |
chr7_121393854_121394773 | 5.10 |
Gm36736 |
predicted gene, 36736 |
1212 |
0.44 |
chr2_21367263_21369086 | 5.09 |
Gpr158 |
G protein-coupled receptor 158 |
607 |
0.59 |
chr7_16946370_16947636 | 5.07 |
Pnmal2 |
PNMA-like 2 |
2321 |
0.14 |
chr2_172040251_172043672 | 5.07 |
Cbln4 |
cerebellin 4 precursor protein |
1505 |
0.35 |
chr3_76073782_76074914 | 5.03 |
Fstl5 |
follistatin-like 5 |
78 |
0.98 |
chr17_43952337_43954220 | 5.02 |
Rcan2 |
regulator of calcineurin 2 |
27 |
0.99 |
chr8_109248831_109249717 | 5.01 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
592 |
0.83 |
chr7_49911362_49912424 | 5.00 |
Slc6a5 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 5 |
193 |
0.96 |
chr5_111422795_111423499 | 4.97 |
Gm43119 |
predicted gene 43119 |
442 |
0.8 |
chr5_33725265_33726907 | 4.96 |
Fgfr3 |
fibroblast growth factor receptor 3 |
2314 |
0.17 |
chr13_83717521_83718816 | 4.96 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
3213 |
0.17 |
chr9_91366433_91367646 | 4.94 |
Zic1 |
zinc finger protein of the cerebellum 1 |
1229 |
0.26 |
chr9_112235046_112235787 | 4.92 |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
398 |
0.75 |
chr4_137664773_137665940 | 4.91 |
Rap1gap |
Rap1 GTPase-activating protein |
602 |
0.71 |
chr13_55484574_55485692 | 4.89 |
Dbn1 |
drebrin 1 |
1164 |
0.26 |
chr5_142702122_142703168 | 4.89 |
Slc29a4 |
solute carrier family 29 (nucleoside transporters), member 4 |
544 |
0.76 |
chr16_94996546_94998023 | 4.88 |
Kcnj6 |
potassium inwardly-rectifying channel, subfamily J, member 6 |
32 |
0.99 |
chr9_106147912_106149765 | 4.84 |
D030055H07Rik |
RIKEN cDNA D030055H07 gene |
151 |
0.9 |
chrX_135210129_135210918 | 4.84 |
Tceal6 |
transcription elongation factor A (SII)-like 6 |
164 |
0.93 |
chr12_98572639_98572973 | 4.82 |
Kcnk10 |
potassium channel, subfamily K, member 10 |
1906 |
0.26 |
chr11_108926426_108927821 | 4.82 |
Axin2 |
axin 2 |
3942 |
0.24 |
chr4_110285468_110287125 | 4.80 |
Elavl4 |
ELAV like RNA binding protein 4 |
320 |
0.94 |
chr11_33195808_33198485 | 4.80 |
Tlx3 |
T cell leukemia, homeobox 3 |
6443 |
0.15 |
chr6_55678280_55679200 | 4.79 |
Neurod6 |
neurogenic differentiation 6 |
2523 |
0.32 |
chr7_46509684_46510322 | 4.76 |
Gm45311 |
predicted gene 45311 |
2777 |
0.23 |
chr1_42686011_42687379 | 4.76 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
6398 |
0.14 |
chr13_83735558_83735982 | 4.73 |
Gm33366 |
predicted gene, 33366 |
2765 |
0.16 |
chr5_120433178_120434996 | 4.72 |
Gm27199 |
predicted gene 27199 |
2320 |
0.19 |
chr8_14381737_14382325 | 4.72 |
Dlgap2 |
DLG associated protein 2 |
35 |
0.98 |
chr2_66633862_66635239 | 4.68 |
Scn9a |
sodium channel, voltage-gated, type IX, alpha |
103 |
0.98 |
chr7_91090740_91091963 | 4.68 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
623 |
0.71 |
chr18_62323543_62324195 | 4.67 |
Htr4 |
5 hydroxytryptamine (serotonin) receptor 4 |
335 |
0.93 |
chr6_116056244_116057282 | 4.67 |
Tmcc1 |
transmembrane and coiled coil domains 1 |
192 |
0.94 |
chr4_72195085_72196381 | 4.64 |
Tle1 |
transducin-like enhancer of split 1 |
3359 |
0.26 |
chr15_74516560_74519631 | 4.59 |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
1264 |
0.47 |
chr13_13391237_13391829 | 4.58 |
Gpr137b |
G protein-coupled receptor 137B |
195 |
0.9 |
chr11_102394791_102396113 | 4.58 |
Rundc3a |
RUN domain containing 3A |
2049 |
0.17 |
chr14_122484799_122486138 | 4.57 |
Gm10837 |
predicted gene 10837 |
5118 |
0.12 |
chr10_34299043_34301066 | 4.57 |
Tspyl4 |
TSPY-like 4 |
798 |
0.4 |
chr5_88583963_88584847 | 4.57 |
Rufy3 |
RUN and FYVE domain containing 3 |
611 |
0.7 |
chr5_38276372_38278048 | 4.57 |
Otop1 |
otopetrin 1 |
194 |
0.92 |
chr8_122750756_122751439 | 4.56 |
C230057M02Rik |
RIKEN cDNA C230057M02 gene |
1228 |
0.3 |
chr12_3236855_3237648 | 4.55 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
640 |
0.66 |
chr3_88210777_88211200 | 4.55 |
Gm3764 |
predicted gene 3764 |
1516 |
0.18 |
chr5_130448513_130449808 | 4.55 |
Caln1 |
calneuron 1 |
359 |
0.91 |
chr4_126465012_126466992 | 4.54 |
Ago1 |
argonaute RISC catalytic subunit 1 |
2419 |
0.18 |
chr13_12647968_12648633 | 4.53 |
Gpr137b-ps |
G protein-coupled receptor 137B, pseudogene |
1693 |
0.24 |
chr2_181763361_181764530 | 4.53 |
Myt1 |
myelin transcription factor 1 |
613 |
0.66 |
chr10_29145584_29145749 | 4.50 |
Gm9996 |
predicted gene 9996 |
1472 |
0.31 |
chr14_122475443_122476757 | 4.48 |
Zic2 |
zinc finger protein of the cerebellum 2 |
665 |
0.44 |
chr7_5056231_5057716 | 4.48 |
Gm15510 |
predicted gene 15510 |
53 |
0.48 |
chr14_64591036_64591686 | 4.47 |
Mir3078 |
microRNA 3078 |
176 |
0.84 |
chr15_98636285_98636620 | 4.45 |
Cacnb3 |
calcium channel, voltage-dependent, beta 3 subunit |
1347 |
0.26 |
chr10_116017652_116019652 | 4.45 |
Ptprr |
protein tyrosine phosphatase, receptor type, R |
365 |
0.92 |
chr9_124439879_124441093 | 4.43 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
382 |
0.83 |
chr14_68085761_68086317 | 4.43 |
Nefl |
neurofilament, light polypeptide |
2176 |
0.29 |
chr7_29314313_29315903 | 4.42 |
Dpf1 |
D4, zinc and double PHD fingers family 1 |
45 |
0.96 |
chr11_120046152_120046417 | 4.41 |
Aatk |
apoptosis-associated tyrosine kinase |
786 |
0.45 |
chr8_94869714_94871671 | 4.38 |
Dok4 |
docking protein 4 |
512 |
0.65 |
chr10_81024569_81025640 | 4.38 |
Gm16099 |
predicted gene 16099 |
21 |
0.8 |
chr2_156614815_156615561 | 4.38 |
Gm14174 |
predicted gene 14174 |
260 |
0.82 |
chr12_30372306_30373643 | 4.37 |
Sntg2 |
syntrophin, gamma 2 |
291 |
0.93 |
chr10_80136789_80138006 | 4.35 |
Cbarp |
calcium channel, voltage-dependent, beta subunit associated regulatory protein |
10 |
0.93 |
chr13_99443316_99444666 | 4.33 |
Map1b |
microtubule-associated protein 1B |
47 |
0.98 |
chr17_34630186_34631263 | 4.32 |
Prrt1 |
proline-rich transmembrane protein 1 |
680 |
0.34 |
chr13_99446279_99447668 | 4.31 |
Map1b |
microtubule-associated protein 1B |
647 |
0.72 |
chr17_48932346_48933546 | 4.30 |
Lrfn2 |
leucine rich repeat and fibronectin type III domain containing 2 |
567 |
0.85 |
chr12_29534253_29535510 | 4.30 |
Gm20208 |
predicted gene, 20208 |
10 |
0.8 |
chr15_89532557_89533956 | 4.30 |
Shank3 |
SH3 and multiple ankyrin repeat domains 3 |
366 |
0.78 |
chr11_115383557_115384476 | 4.30 |
Cdr2l |
cerebellar degeneration-related protein 2-like |
2100 |
0.15 |
chr16_16558986_16560577 | 4.30 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
209 |
0.94 |
chr4_42950234_42951162 | 4.29 |
Dnajb5 |
DnaJ heat shock protein family (Hsp40) member B5 |
258 |
0.87 |
chr1_152086908_152087700 | 4.29 |
1700025G04Rik |
RIKEN cDNA 1700025G04 gene |
2666 |
0.35 |
chr3_134236641_134237783 | 4.28 |
Cxxc4 |
CXXC finger 4 |
392 |
0.78 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 16.1 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
4.6 | 13.8 | GO:0021586 | pons maturation(GO:0021586) |
4.4 | 13.2 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
4.3 | 12.8 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
4.0 | 15.9 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
3.8 | 11.4 | GO:0061642 | chemoattraction of axon(GO:0061642) |
3.5 | 10.5 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
3.2 | 12.9 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
3.1 | 9.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
3.0 | 29.5 | GO:0071625 | vocalization behavior(GO:0071625) |
2.9 | 2.9 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
2.9 | 5.9 | GO:0007412 | axon target recognition(GO:0007412) |
2.9 | 8.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.8 | 11.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
2.8 | 2.8 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
2.8 | 5.6 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
2.8 | 16.7 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
2.8 | 2.8 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
2.7 | 22.0 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
2.6 | 23.6 | GO:0097120 | receptor localization to synapse(GO:0097120) |
2.6 | 7.8 | GO:0072221 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
2.5 | 12.5 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
2.5 | 12.4 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
2.4 | 7.3 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
2.4 | 21.9 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
2.4 | 11.9 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
2.3 | 2.3 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
2.3 | 4.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
2.2 | 18.0 | GO:0070253 | somatostatin secretion(GO:0070253) |
2.2 | 6.6 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
2.2 | 17.6 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
2.2 | 6.5 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
2.2 | 4.3 | GO:0060594 | mammary gland specification(GO:0060594) |
2.2 | 8.6 | GO:0061743 | motor learning(GO:0061743) |
2.1 | 8.6 | GO:0023041 | neuronal signal transduction(GO:0023041) |
2.1 | 10.5 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
2.1 | 10.5 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
2.1 | 6.3 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
2.1 | 8.2 | GO:0060174 | limb bud formation(GO:0060174) |
2.0 | 10.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
2.0 | 4.1 | GO:0072289 | metanephric nephron tubule formation(GO:0072289) |
2.0 | 6.1 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
2.0 | 5.9 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
2.0 | 5.9 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
2.0 | 5.9 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.9 | 1.9 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
1.9 | 5.8 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
1.9 | 7.7 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.9 | 1.9 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.9 | 7.5 | GO:0030035 | microspike assembly(GO:0030035) |
1.9 | 15.0 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
1.9 | 3.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.9 | 9.4 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
1.9 | 5.6 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.8 | 9.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
1.8 | 5.5 | GO:0021550 | medulla oblongata development(GO:0021550) |
1.8 | 9.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
1.8 | 3.6 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
1.8 | 5.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.8 | 5.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
1.7 | 19.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
1.7 | 3.5 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
1.7 | 1.7 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.7 | 34.5 | GO:0001964 | startle response(GO:0001964) |
1.7 | 6.9 | GO:1990035 | calcium ion import into cell(GO:1990035) |
1.7 | 20.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.7 | 5.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.7 | 3.4 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
1.6 | 6.6 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.6 | 8.0 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.6 | 6.4 | GO:0021637 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
1.6 | 11.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.6 | 4.8 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
1.6 | 4.8 | GO:0009629 | response to gravity(GO:0009629) |
1.6 | 7.9 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.6 | 4.7 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.6 | 3.1 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.6 | 3.1 | GO:0046959 | habituation(GO:0046959) |
1.5 | 3.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
1.5 | 6.1 | GO:0060278 | regulation of ovulation(GO:0060278) |
1.5 | 4.4 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.5 | 5.9 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.4 | 5.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.4 | 4.3 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
1.4 | 2.9 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
1.4 | 16.9 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
1.4 | 2.8 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
1.4 | 8.3 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.4 | 2.7 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
1.4 | 4.1 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
1.4 | 2.7 | GO:0014016 | neuroblast differentiation(GO:0014016) |
1.4 | 10.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.3 | 5.4 | GO:0090427 | activation of meiosis(GO:0090427) |
1.3 | 5.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
1.3 | 9.4 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
1.3 | 6.7 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.3 | 5.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.3 | 71.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.3 | 2.6 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.3 | 6.5 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
1.3 | 3.9 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
1.3 | 1.3 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.2 | 3.7 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.2 | 3.7 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
1.2 | 1.2 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
1.2 | 4.9 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
1.2 | 9.7 | GO:0008038 | neuron recognition(GO:0008038) |
1.2 | 4.8 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
1.2 | 2.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.2 | 10.7 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
1.2 | 5.9 | GO:0035902 | response to immobilization stress(GO:0035902) |
1.2 | 4.7 | GO:0006538 | glutamate catabolic process(GO:0006538) |
1.2 | 29.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
1.2 | 38.7 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
1.2 | 3.5 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
1.2 | 1.2 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
1.1 | 3.4 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
1.1 | 2.3 | GO:0021559 | trigeminal nerve development(GO:0021559) |
1.1 | 2.3 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
1.1 | 2.3 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
1.1 | 2.3 | GO:0046958 | nonassociative learning(GO:0046958) |
1.1 | 3.4 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
1.1 | 9.0 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
1.1 | 4.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.1 | 2.2 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
1.1 | 3.3 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
1.1 | 3.3 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
1.1 | 3.3 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
1.1 | 3.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.1 | 4.3 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.1 | 7.5 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
1.1 | 5.4 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.1 | 3.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.1 | 3.2 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.0 | 3.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
1.0 | 5.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
1.0 | 4.0 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
1.0 | 8.9 | GO:0021978 | telencephalon regionalization(GO:0021978) |
1.0 | 6.8 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
1.0 | 2.0 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
1.0 | 2.0 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.0 | 1.0 | GO:0061551 | cranial ganglion development(GO:0061550) trigeminal ganglion development(GO:0061551) |
1.0 | 3.9 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.0 | 11.7 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
1.0 | 6.8 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
1.0 | 6.8 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
1.0 | 1.0 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
1.0 | 3.8 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.9 | 0.9 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.9 | 0.9 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.9 | 7.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.9 | 1.9 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.9 | 15.7 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.9 | 1.8 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.9 | 3.7 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.9 | 1.8 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.9 | 10.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.9 | 8.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.9 | 2.7 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.9 | 1.8 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.9 | 1.8 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.9 | 0.9 | GO:0061205 | paramesonephric duct development(GO:0061205) |
0.9 | 2.6 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.9 | 1.8 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.9 | 14.1 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.9 | 3.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.9 | 0.9 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.9 | 1.7 | GO:0090135 | actin filament branching(GO:0090135) |
0.9 | 2.6 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.9 | 3.5 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.9 | 5.2 | GO:0007614 | short-term memory(GO:0007614) |
0.9 | 3.4 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.9 | 0.9 | GO:0061549 | sympathetic ganglion development(GO:0061549) |
0.9 | 2.6 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.9 | 0.9 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.9 | 2.6 | GO:0001555 | oocyte growth(GO:0001555) |
0.8 | 0.8 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.8 | 10.0 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.8 | 2.5 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.8 | 4.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.8 | 1.6 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.8 | 23.8 | GO:0019228 | neuronal action potential(GO:0019228) |
0.8 | 0.8 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.8 | 0.8 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.8 | 1.6 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.8 | 0.8 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
0.8 | 2.4 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.8 | 2.4 | GO:0030432 | peristalsis(GO:0030432) |
0.8 | 1.6 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.8 | 1.6 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.8 | 0.8 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.8 | 2.4 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.8 | 4.0 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.8 | 3.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.8 | 2.4 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.8 | 0.8 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.8 | 58.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.8 | 0.8 | GO:0035106 | operant conditioning(GO:0035106) |
0.8 | 0.8 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.8 | 1.6 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.8 | 2.3 | GO:0015888 | thiamine transport(GO:0015888) |
0.8 | 13.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.8 | 2.3 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.8 | 1.5 | GO:0099612 | protein localization to axon(GO:0099612) |
0.8 | 0.8 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.8 | 2.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.8 | 0.8 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.8 | 0.8 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.8 | 0.8 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.8 | 0.8 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.7 | 2.2 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.7 | 0.7 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.7 | 2.2 | GO:0048664 | neuron fate determination(GO:0048664) |
0.7 | 1.5 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.7 | 3.0 | GO:0072044 | collecting duct development(GO:0072044) |
0.7 | 2.2 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.7 | 2.2 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.7 | 3.0 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.7 | 2.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.7 | 1.5 | GO:0060166 | olfactory pit development(GO:0060166) |
0.7 | 2.9 | GO:0060023 | soft palate development(GO:0060023) |
0.7 | 2.9 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.7 | 2.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.7 | 0.7 | GO:0061054 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
0.7 | 2.9 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.7 | 2.2 | GO:0006868 | glutamine transport(GO:0006868) |
0.7 | 2.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.7 | 9.9 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.7 | 2.8 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.7 | 2.8 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.7 | 1.4 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.7 | 2.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.7 | 4.8 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.7 | 2.7 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.7 | 2.0 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.7 | 6.1 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.7 | 3.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.7 | 2.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.7 | 2.0 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.7 | 3.3 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.7 | 5.3 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.7 | 1.3 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.7 | 2.0 | GO:0015744 | succinate transport(GO:0015744) |
0.7 | 2.6 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.7 | 2.6 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.7 | 2.6 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.6 | 3.2 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.6 | 1.9 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.6 | 1.9 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.6 | 0.6 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.6 | 9.5 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.6 | 0.6 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.6 | 3.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.6 | 1.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.6 | 1.9 | GO:0072429 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.6 | 1.8 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.6 | 6.1 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.6 | 0.6 | GO:0015705 | iodide transport(GO:0015705) |
0.6 | 1.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.6 | 1.8 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.6 | 2.4 | GO:1902913 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.6 | 0.6 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.6 | 11.2 | GO:0021766 | hippocampus development(GO:0021766) |
0.6 | 8.2 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.6 | 4.1 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.6 | 4.7 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.6 | 1.7 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.6 | 0.6 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.6 | 2.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.6 | 1.7 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
0.6 | 0.6 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.6 | 2.3 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.6 | 15.8 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.6 | 2.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.6 | 2.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.6 | 2.8 | GO:0097264 | self proteolysis(GO:0097264) |
0.6 | 2.2 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
0.6 | 2.2 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.6 | 1.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.6 | 0.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.6 | 0.6 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.6 | 2.8 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.5 | 1.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.5 | 2.2 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.5 | 4.3 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.5 | 2.1 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.5 | 3.7 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.5 | 3.7 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.5 | 2.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.5 | 8.3 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.5 | 4.7 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.5 | 1.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.5 | 1.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.5 | 1.0 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.5 | 2.6 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.5 | 45.1 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.5 | 1.0 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.5 | 2.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.5 | 1.5 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.5 | 0.5 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.5 | 2.0 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.5 | 1.5 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.5 | 12.2 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.5 | 2.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.5 | 1.0 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.5 | 1.5 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.5 | 0.5 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.5 | 1.0 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.5 | 3.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.5 | 1.5 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.5 | 1.0 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.5 | 1.5 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.5 | 1.0 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.5 | 11.8 | GO:0099531 | presynaptic process involved in chemical synaptic transmission(GO:0099531) |
0.5 | 1.5 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.5 | 2.4 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.5 | 1.5 | GO:0010288 | response to lead ion(GO:0010288) |
0.5 | 0.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.5 | 1.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.5 | 2.8 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.5 | 3.7 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.5 | 0.5 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
0.5 | 0.9 | GO:0014075 | response to amine(GO:0014075) |
0.5 | 0.9 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.5 | 0.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.5 | 1.4 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.5 | 0.9 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.5 | 1.4 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.5 | 1.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.5 | 0.9 | GO:0051593 | response to folic acid(GO:0051593) |
0.5 | 0.5 | GO:0021546 | rhombomere development(GO:0021546) |
0.5 | 1.8 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.5 | 1.8 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.5 | 4.1 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.5 | 3.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.4 | 1.3 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.4 | 1.8 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.4 | 0.9 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.4 | 0.9 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.4 | 0.9 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.4 | 9.7 | GO:0071242 | cellular response to ammonium ion(GO:0071242) |
0.4 | 0.4 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.4 | 1.3 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.4 | 1.3 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.4 | 0.4 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.4 | 3.5 | GO:0060074 | synapse maturation(GO:0060074) |
0.4 | 3.0 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.4 | 3.5 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.4 | 1.7 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.4 | 0.9 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.4 | 5.2 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.4 | 6.0 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.4 | 0.4 | GO:0051588 | regulation of neurotransmitter transport(GO:0051588) |
0.4 | 9.0 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.4 | 0.4 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.4 | 5.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.4 | 0.8 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.4 | 0.4 | GO:0044849 | estrous cycle(GO:0044849) |
0.4 | 0.4 | GO:0031650 | regulation of heat generation(GO:0031650) |
0.4 | 6.5 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.4 | 1.2 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.4 | 1.6 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.4 | 1.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.4 | 0.8 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.4 | 1.2 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.4 | 0.4 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.4 | 1.2 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.4 | 0.4 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.4 | 1.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.4 | 3.6 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.4 | 0.8 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.4 | 1.2 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.4 | 0.8 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.4 | 11.3 | GO:0034605 | cellular response to heat(GO:0034605) |
0.4 | 0.8 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.4 | 5.8 | GO:0032401 | establishment of melanosome localization(GO:0032401) |
0.4 | 1.5 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.4 | 1.5 | GO:0015884 | folic acid transport(GO:0015884) |
0.4 | 1.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.4 | 1.1 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.4 | 1.5 | GO:0007616 | long-term memory(GO:0007616) |
0.4 | 1.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.4 | 0.4 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.4 | 1.1 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.4 | 17.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.4 | 1.1 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.4 | 1.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.4 | 0.7 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.4 | 1.4 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.4 | 4.0 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.4 | 2.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.4 | 1.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.4 | 1.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.4 | 0.4 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.4 | 1.1 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.4 | 1.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.4 | 2.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.4 | 1.1 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.4 | 1.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.4 | 0.7 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.4 | 9.8 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.4 | 3.9 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.4 | 1.4 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 9.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.3 | 30.9 | GO:0007409 | axonogenesis(GO:0007409) |
0.3 | 0.7 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.3 | 0.7 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.3 | 6.5 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.3 | 3.4 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.3 | 31.3 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.3 | 0.3 | GO:1901321 | positive regulation of heart induction(GO:1901321) |
0.3 | 1.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.3 | 0.7 | GO:0007619 | courtship behavior(GO:0007619) |
0.3 | 0.3 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.3 | 1.0 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.3 | 0.3 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.3 | 1.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.3 | 1.0 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.3 | 2.7 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.3 | 0.7 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.3 | 2.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.3 | 2.9 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.3 | 1.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 0.3 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.3 | 2.9 | GO:0001967 | suckling behavior(GO:0001967) |
0.3 | 1.0 | GO:0097503 | sialylation(GO:0097503) |
0.3 | 1.0 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.3 | 1.0 | GO:0061622 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process through glucose-1-phosphate(GO:0061622) glycolytic process from galactose(GO:0061623) |
0.3 | 0.3 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.3 | 0.3 | GO:0072553 | terminal button organization(GO:0072553) |
0.3 | 1.3 | GO:0060004 | reflex(GO:0060004) |
0.3 | 0.3 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.3 | 0.6 | GO:0014028 | notochord formation(GO:0014028) |
0.3 | 0.3 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.3 | 1.9 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.3 | 0.3 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.3 | 1.5 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.3 | 0.9 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.3 | 0.3 | GO:0003128 | heart field specification(GO:0003128) |
0.3 | 0.3 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.3 | 0.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.3 | 13.4 | GO:0050808 | synapse organization(GO:0050808) |
0.3 | 0.9 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.3 | 0.3 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.3 | 0.6 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.3 | 2.7 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.3 | 2.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.3 | 0.9 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.3 | 3.6 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.3 | 0.9 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 0.6 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.3 | 0.3 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.3 | 1.8 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.3 | 1.8 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.3 | 0.3 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.3 | 1.2 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.3 | 0.9 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.3 | 0.8 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.3 | 0.8 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.3 | 1.7 | GO:0015846 | polyamine transport(GO:0015846) |
0.3 | 0.6 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.3 | 0.8 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.3 | 0.6 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.3 | 2.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.3 | 0.6 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.3 | 0.8 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
0.3 | 1.4 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.3 | 1.1 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.3 | 2.2 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.3 | 0.3 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.3 | 0.8 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.3 | 0.8 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.3 | 3.8 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.3 | 1.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.3 | 15.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.3 | 3.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.3 | 0.8 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 0.8 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.3 | 1.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 0.3 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.3 | 2.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.3 | 1.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.3 | 1.8 | GO:0010092 | specification of organ identity(GO:0010092) |
0.3 | 0.3 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.3 | 1.0 | GO:0035627 | ceramide transport(GO:0035627) |
0.3 | 0.5 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.2 | 0.7 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.2 | 1.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.2 | 0.5 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 | 0.5 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.2 | 0.5 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 0.2 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.2 | 0.7 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 1.9 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.2 | 1.9 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.2 | 0.2 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.2 | 0.2 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
0.2 | 1.0 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.2 | 0.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.7 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 0.2 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.2 | 0.5 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.2 | 1.9 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.2 | 0.7 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.2 | 2.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.2 | 1.6 | GO:0090399 | replicative senescence(GO:0090399) |
0.2 | 0.7 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.2 | 0.5 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.2 | 0.9 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.2 | 1.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 0.7 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 0.4 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 0.4 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 0.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.2 | 1.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 2.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 0.7 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 0.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.6 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.2 | 1.1 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.2 | 0.6 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.2 | 0.6 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.2 | 0.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 1.5 | GO:0070417 | cellular response to cold(GO:0070417) |
0.2 | 0.6 | GO:0043584 | nose development(GO:0043584) |
0.2 | 0.4 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.2 | 0.6 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 0.6 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 1.9 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.2 | 1.0 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.2 | 0.8 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.2 | 2.7 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.2 | 0.4 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.2 | 0.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 0.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 0.6 | GO:0032202 | telomere assembly(GO:0032202) |
0.2 | 2.8 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.2 | 0.6 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.2 | 0.2 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.2 | 1.2 | GO:0031112 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) |
0.2 | 0.2 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.2 | 0.4 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.2 | 0.6 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.2 | 0.6 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 0.2 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.2 | 1.0 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.2 | 0.4 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.2 | 1.4 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.2 | 0.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 1.3 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.2 | 0.2 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.2 | 0.2 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.2 | 0.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 1.5 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.2 | 0.6 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 1.7 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.2 | 0.7 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 0.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 0.2 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.2 | 0.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.2 | 3.7 | GO:0008306 | associative learning(GO:0008306) |
0.2 | 0.7 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 0.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 2.0 | GO:0030901 | midbrain development(GO:0030901) |
0.2 | 4.3 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 0.5 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.2 | 0.5 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.2 | 0.2 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.2 | 1.2 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.2 | 0.4 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 1.8 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 0.5 | GO:0040031 | snRNA modification(GO:0040031) |
0.2 | 0.2 | GO:0070666 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.2 | 0.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 0.7 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 1.9 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 0.7 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 0.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 1.0 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 0.7 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 0.3 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.2 | 1.8 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.2 | 0.3 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.5 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.2 | 0.8 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.2 | 1.1 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 1.4 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.2 | 1.6 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.2 | 0.6 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 6.5 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.2 | 0.9 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 3.5 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.2 | 0.5 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 0.3 | GO:0042938 | dipeptide transport(GO:0042938) |
0.2 | 0.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 0.2 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.2 | 0.3 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.2 | 0.5 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 0.2 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.2 | 0.6 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.2 | 0.5 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.2 | 0.2 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.2 | 0.3 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.2 | 0.6 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.2 | 1.1 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.4 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.1 | 0.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.4 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.4 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 2.8 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.6 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.1 | 0.7 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.3 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.8 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.1 | 0.1 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.1 | 1.4 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.6 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.6 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.1 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 0.3 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.1 | 0.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.4 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 0.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.3 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.1 | 7.4 | GO:0010976 | positive regulation of neuron projection development(GO:0010976) |
0.1 | 1.1 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.7 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.4 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 0.6 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.1 | 1.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.5 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.3 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.3 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.1 | 0.2 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 0.2 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 0.1 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.6 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 1.2 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.1 | 0.1 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.1 | 0.1 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.1 | 0.1 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.1 | 0.4 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.4 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.2 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.1 | 0.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.1 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.1 | 0.7 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.1 | 0.1 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.1 | 0.7 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 1.0 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.3 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 1.5 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.1 | 1.9 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.9 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.1 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.1 | 0.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.8 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.1 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 1.3 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 0.7 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.4 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.3 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.4 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.3 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.4 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.1 | 0.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.3 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.1 | 0.1 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.1 | 0.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.1 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.1 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 1.8 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.1 | 0.1 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.1 | 0.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.2 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.2 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.3 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.3 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.1 | 0.4 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.3 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.8 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.1 | 0.8 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.1 | 0.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.3 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.1 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.1 | 1.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 1.7 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.3 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.1 | 3.8 | GO:0098916 | chemical synaptic transmission(GO:0007268) anterograde trans-synaptic signaling(GO:0098916) trans-synaptic signaling(GO:0099537) |
0.1 | 0.4 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 2.7 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.1 | 0.2 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) histone mRNA metabolic process(GO:0008334) |
0.1 | 0.2 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.1 | 0.3 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 1.9 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.1 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.1 | 2.4 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.1 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.1 | 0.2 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.1 | 0.2 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.1 | 0.2 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.1 | 0.1 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 0.2 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.2 | GO:0003140 | determination of left/right asymmetry in lateral mesoderm(GO:0003140) |
0.1 | 2.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.7 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.4 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 0.5 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.2 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.2 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.1 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.6 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.1 | 0.1 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 0.4 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.4 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.9 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.4 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.1 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.1 | 0.6 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.1 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.1 | 0.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.2 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.8 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.7 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.2 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.1 | 0.5 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.9 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.4 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.2 | GO:0090102 | cochlea development(GO:0090102) |
0.1 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.1 | GO:1901160 | primary amino compound metabolic process(GO:1901160) |
0.1 | 0.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.1 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.1 | 0.1 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.1 | 0.2 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 0.1 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.1 | 0.3 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.1 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.1 | 0.3 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.2 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 0.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.2 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 0.1 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.1 | 0.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.2 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.2 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.4 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.0 | 0.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.0 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.0 | 0.5 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.2 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.0 | 0.9 | GO:0044088 | regulation of vacuole organization(GO:0044088) |
0.0 | 0.0 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.0 | 0.1 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.0 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.0 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.0 | 0.2 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.0 | 0.0 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.0 | 0.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.0 | 0.2 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 0.1 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.0 | 0.2 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.0 | 0.0 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.0 | 0.0 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.0 | 0.2 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.0 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.0 | 0.0 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.0 | 0.0 | GO:0021924 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.0 | 0.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.3 | GO:0007099 | centriole replication(GO:0007099) |
0.0 | 0.0 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.0 | 0.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.0 | 0.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.0 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.0 | 0.0 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.0 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.0 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.0 | 0.0 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.0 | 0.1 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.0 | 0.0 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) |
0.0 | 0.2 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.1 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.3 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.0 | 0.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.1 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.0 | 0.1 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.0 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.0 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.0 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.1 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.0 | 0.8 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.0 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.8 | GO:0048812 | neuron projection morphogenesis(GO:0048812) |
0.0 | 0.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.0 | 0.0 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.0 | 0.1 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.1 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.0 | 0.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.0 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.2 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.3 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.1 | GO:0051256 | mitotic spindle elongation(GO:0000022) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
0.0 | 0.0 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.0 | GO:0015817 | histidine transport(GO:0015817) |
0.0 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.5 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.0 | 0.0 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.0 | 0.0 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.0 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 10.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
3.2 | 3.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
2.7 | 2.7 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
2.4 | 24.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
2.4 | 18.9 | GO:0043083 | synaptic cleft(GO:0043083) |
2.2 | 13.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
2.1 | 18.8 | GO:0005883 | neurofilament(GO:0005883) |
2.1 | 57.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
2.0 | 37.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.9 | 17.2 | GO:0016342 | catenin complex(GO:0016342) |
1.8 | 14.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.6 | 1.6 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.6 | 4.9 | GO:0044308 | axonal spine(GO:0044308) |
1.6 | 4.7 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.5 | 1.5 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.5 | 8.9 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.5 | 14.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.5 | 8.8 | GO:0032584 | growth cone membrane(GO:0032584) |
1.4 | 70.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.4 | 16.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.4 | 13.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.4 | 33.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
1.3 | 4.0 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.3 | 4.0 | GO:0072534 | perineuronal net(GO:0072534) |
1.3 | 35.9 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
1.3 | 3.9 | GO:0044393 | microspike(GO:0044393) |
1.3 | 28.0 | GO:0044295 | axonal growth cone(GO:0044295) |
1.2 | 3.7 | GO:0032280 | symmetric synapse(GO:0032280) |
1.2 | 2.4 | GO:0044326 | dendritic spine neck(GO:0044326) |
1.1 | 9.1 | GO:0033268 | node of Ranvier(GO:0033268) |
1.1 | 4.6 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.1 | 15.9 | GO:0071565 | nBAF complex(GO:0071565) |
1.1 | 4.3 | GO:0043194 | axon initial segment(GO:0043194) |
1.0 | 11.5 | GO:0035102 | PRC1 complex(GO:0035102) |
1.0 | 2.0 | GO:1990635 | proximal dendrite(GO:1990635) |
1.0 | 5.8 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
1.0 | 1.9 | GO:0016514 | SWI/SNF complex(GO:0016514) |
1.0 | 8.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.9 | 6.6 | GO:0030673 | axolemma(GO:0030673) |
0.9 | 1.8 | GO:0043219 | lateral loop(GO:0043219) |
0.9 | 3.6 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.9 | 8.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.9 | 4.4 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.9 | 2.6 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.9 | 11.1 | GO:0043196 | varicosity(GO:0043196) |
0.8 | 4.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.8 | 4.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.8 | 26.5 | GO:0043198 | dendritic shaft(GO:0043198) |
0.8 | 0.8 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.8 | 7.0 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.8 | 109.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.8 | 2.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.8 | 33.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.7 | 1.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.7 | 67.4 | GO:0030426 | growth cone(GO:0030426) |
0.7 | 2.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.7 | 1.5 | GO:0097441 | basilar dendrite(GO:0097441) |
0.7 | 17.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.7 | 1.5 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.7 | 2.9 | GO:0070852 | cell body fiber(GO:0070852) |
0.7 | 2.8 | GO:0061574 | ASAP complex(GO:0061574) |
0.7 | 0.7 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.7 | 6.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.7 | 2.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.7 | 2.0 | GO:0042583 | chromaffin granule(GO:0042583) |
0.6 | 44.3 | GO:0043204 | perikaryon(GO:0043204) |
0.6 | 3.8 | GO:0043203 | axon hillock(GO:0043203) |
0.6 | 1.8 | GO:1990696 | USH2 complex(GO:1990696) |
0.6 | 0.6 | GO:0016939 | kinesin II complex(GO:0016939) |
0.6 | 10.5 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.5 | 10.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.5 | 2.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.5 | 3.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.5 | 1.5 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.5 | 2.5 | GO:0097433 | dense body(GO:0097433) |
0.5 | 2.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.5 | 1.5 | GO:1990393 | 3M complex(GO:1990393) |
0.5 | 1.0 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.5 | 1.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.5 | 7.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.5 | 5.4 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.4 | 1.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.4 | 7.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.4 | 0.9 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.4 | 2.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 18.2 | GO:0043195 | terminal bouton(GO:0043195) |
0.4 | 3.9 | GO:0031527 | filopodium membrane(GO:0031527) |
0.4 | 0.8 | GO:0034705 | potassium channel complex(GO:0034705) |
0.4 | 4.0 | GO:0034704 | calcium channel complex(GO:0034704) |
0.4 | 0.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.4 | 1.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.4 | 1.5 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 2.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.4 | 1.4 | GO:0070545 | PeBoW complex(GO:0070545) |
0.4 | 20.3 | GO:0098793 | presynapse(GO:0098793) |
0.3 | 2.7 | GO:0000812 | Swr1 complex(GO:0000812) |
0.3 | 80.1 | GO:0045202 | synapse(GO:0045202) |
0.3 | 0.7 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.3 | 1.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 0.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.3 | 1.0 | GO:0043511 | inhibin complex(GO:0043511) |
0.3 | 4.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.3 | 1.0 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.3 | 3.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 2.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.3 | 38.5 | GO:0030424 | axon(GO:0030424) |
0.3 | 0.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 2.9 | GO:0031512 | motile primary cilium(GO:0031512) |
0.3 | 1.2 | GO:1990745 | EARP complex(GO:1990745) |
0.3 | 2.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.3 | 1.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 2.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 0.8 | GO:0031417 | NatC complex(GO:0031417) |
0.3 | 1.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.3 | 0.8 | GO:0030689 | Noc complex(GO:0030689) |
0.2 | 1.0 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 0.2 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 30.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 0.2 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 0.2 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.2 | 0.7 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 0.7 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 1.2 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 0.9 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 2.2 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 0.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 1.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 1.1 | GO:0032590 | dendrite membrane(GO:0032590) |
0.2 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 0.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 0.4 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 2.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 1.8 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 0.6 | GO:0000802 | transverse filament(GO:0000802) |
0.2 | 0.6 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 0.9 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.2 | 1.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 3.5 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 0.4 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.2 | 0.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 0.4 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.2 | 0.9 | GO:0005687 | U4 snRNP(GO:0005687) |
0.2 | 0.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 3.5 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 0.9 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 0.2 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 0.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 0.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 0.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 0.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.2 | 0.5 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 1.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 1.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 1.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.9 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 8.5 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.1 | 0.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 2.7 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 0.9 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 1.1 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 5.8 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 0.4 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 0.4 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 29.5 | GO:0043005 | neuron projection(GO:0043005) |
0.1 | 0.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.7 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 3.3 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 1.1 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 1.3 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 0.4 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 1.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.8 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 2.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.2 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.5 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.9 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.3 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 3.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.4 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 2.5 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 0.5 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.2 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.3 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 1.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.9 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.4 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.2 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 0.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.3 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 3.1 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 4.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 1.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.3 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.2 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.4 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.4 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.1 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.3 | GO:0031082 | BLOC complex(GO:0031082) |
0.0 | 0.0 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 1.3 | GO:0072372 | primary cilium(GO:0072372) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.0 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.0 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 0.1 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.0 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 0.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.0 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.2 | GO:0045120 | pronucleus(GO:0045120) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.1 | 15.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
5.0 | 15.0 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
3.6 | 14.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
3.6 | 10.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
3.3 | 13.4 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
2.8 | 14.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
2.7 | 10.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
2.5 | 19.9 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
2.5 | 7.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
2.5 | 14.8 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
2.4 | 2.4 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
2.4 | 9.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
2.4 | 11.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.3 | 18.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
2.2 | 15.1 | GO:0003680 | AT DNA binding(GO:0003680) |
2.0 | 12.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
2.0 | 15.9 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
2.0 | 3.9 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.9 | 5.6 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.9 | 1.9 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
1.8 | 5.5 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.8 | 7.1 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
1.8 | 7.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
1.7 | 1.7 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
1.6 | 8.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.6 | 4.9 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
1.6 | 7.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.5 | 7.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.5 | 20.9 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
1.5 | 16.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.5 | 4.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.4 | 5.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.4 | 8.6 | GO:0048495 | Roundabout binding(GO:0048495) |
1.4 | 12.5 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.4 | 15.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
1.4 | 4.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
1.3 | 10.7 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
1.3 | 6.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.3 | 26.3 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
1.3 | 3.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.2 | 3.7 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.2 | 6.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.2 | 4.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.2 | 2.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.2 | 6.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.2 | 3.6 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.2 | 1.2 | GO:0038191 | neuropilin binding(GO:0038191) |
1.2 | 6.9 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
1.2 | 3.5 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.1 | 4.6 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.1 | 16.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.1 | 4.6 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.1 | 2.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.1 | 11.4 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.1 | 2.3 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.1 | 3.3 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
1.1 | 5.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.1 | 3.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.1 | 4.4 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.1 | 3.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.1 | 5.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.1 | 2.1 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
1.1 | 4.2 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
1.1 | 3.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
1.0 | 1.0 | GO:0046790 | virion binding(GO:0046790) |
1.0 | 4.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.0 | 4.0 | GO:0046870 | cadmium ion binding(GO:0046870) |
1.0 | 3.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.0 | 20.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.0 | 10.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.9 | 2.8 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.9 | 2.7 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.9 | 2.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.9 | 11.7 | GO:0005272 | sodium channel activity(GO:0005272) |
0.9 | 1.8 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.9 | 6.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.9 | 2.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.9 | 4.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.9 | 8.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.9 | 19.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.9 | 9.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.9 | 2.6 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.9 | 6.0 | GO:0030957 | Tat protein binding(GO:0030957) |
0.8 | 2.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.8 | 2.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.8 | 10.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.8 | 1.7 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.8 | 4.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.8 | 3.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.8 | 16.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.8 | 10.3 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.8 | 1.6 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.8 | 2.4 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.8 | 7.0 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.8 | 9.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.8 | 3.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.8 | 2.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.8 | 10.6 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.8 | 18.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.7 | 3.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.7 | 3.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.7 | 12.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.7 | 3.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.7 | 18.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.7 | 3.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.7 | 2.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.7 | 6.5 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.7 | 17.6 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.7 | 16.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.7 | 1.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.7 | 20.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.7 | 2.7 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.7 | 17.1 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.7 | 3.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.7 | 2.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.7 | 2.0 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.7 | 2.7 | GO:0097001 | ceramide binding(GO:0097001) |
0.7 | 4.0 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.7 | 2.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.7 | 2.0 | GO:0015556 | succinate transmembrane transporter activity(GO:0015141) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.7 | 9.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.6 | 18.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.6 | 0.6 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.6 | 1.3 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.6 | 3.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.6 | 1.8 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.6 | 3.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.6 | 6.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.6 | 4.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.6 | 1.8 | GO:0070052 | collagen V binding(GO:0070052) |
0.6 | 13.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.6 | 1.8 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.6 | 1.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.6 | 1.7 | GO:0018567 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.6 | 7.8 | GO:0030275 | LRR domain binding(GO:0030275) |
0.6 | 6.1 | GO:0005522 | profilin binding(GO:0005522) |
0.5 | 2.7 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.5 | 11.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.5 | 15.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.5 | 5.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.5 | 0.5 | GO:0043398 | HLH domain binding(GO:0043398) |
0.5 | 1.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.5 | 2.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.5 | 1.0 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.5 | 3.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.5 | 2.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.5 | 8.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.5 | 2.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.5 | 2.0 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.5 | 0.5 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.5 | 2.5 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.5 | 3.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.5 | 3.9 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.5 | 1.9 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.5 | 1.4 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.5 | 1.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.5 | 5.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.5 | 3.8 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.5 | 0.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.5 | 0.9 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.5 | 1.9 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.5 | 3.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.4 | 2.2 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.4 | 3.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.4 | 1.3 | GO:0055100 | adiponectin binding(GO:0055100) |
0.4 | 7.8 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.4 | 1.3 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.4 | 0.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.4 | 8.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.4 | 1.2 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.4 | 1.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.4 | 1.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.4 | 3.7 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.4 | 1.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.4 | 1.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.4 | 1.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.4 | 0.4 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.4 | 4.8 | GO:0031005 | filamin binding(GO:0031005) |
0.4 | 6.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.4 | 2.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.4 | 1.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 3.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.4 | 1.2 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.4 | 1.9 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.4 | 1.1 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.4 | 1.9 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.4 | 3.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.4 | 0.8 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.4 | 2.6 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.4 | 4.1 | GO:0015026 | coreceptor activity(GO:0015026) |
0.4 | 1.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.4 | 1.5 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.4 | 6.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.4 | 9.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.4 | 0.4 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.4 | 0.4 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.4 | 2.9 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.4 | 1.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.4 | 1.4 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.4 | 2.8 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.3 | 0.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 3.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 1.0 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.3 | 2.7 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.3 | 0.3 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.3 | 6.0 | GO:0031489 | myosin V binding(GO:0031489) |
0.3 | 6.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 1.0 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.3 | 7.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.3 | 1.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.3 | 2.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.3 | 1.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.3 | 1.9 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 1.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 7.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.3 | 1.0 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.3 | 0.6 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.3 | 0.6 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.3 | 0.6 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.3 | 0.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.3 | 0.6 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.3 | 11.3 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.3 | 4.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.3 | 0.6 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.3 | 0.3 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.3 | 16.5 | GO:0019905 | syntaxin binding(GO:0019905) |
0.3 | 0.9 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.3 | 8.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.3 | 0.9 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.3 | 4.6 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.3 | 7.2 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.3 | 1.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 0.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 2.6 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.3 | 0.9 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.3 | 2.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 1.2 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.3 | 11.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 1.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 0.9 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.3 | 1.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 0.6 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.3 | 6.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.3 | 0.3 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.3 | 1.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 0.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.3 | 0.8 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.3 | 2.9 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.3 | 0.8 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 3.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 0.5 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 2.8 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.3 | 1.5 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 1.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 1.7 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 1.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 2.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.2 | 0.9 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 4.2 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.2 | 0.7 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.2 | 0.9 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 3.9 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.2 | 1.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 0.7 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.2 | 0.2 | GO:0005119 | smoothened binding(GO:0005119) |
0.2 | 4.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 0.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 1.8 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 1.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 2.2 | GO:0052736 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.2 | 3.7 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 1.7 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 1.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.2 | 0.7 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 2.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 1.5 | GO:0030553 | cGMP binding(GO:0030553) |
0.2 | 1.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 2.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 1.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 1.9 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 1.0 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 3.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 4.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 1.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 1.0 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 1.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 1.5 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 3.2 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.2 | 0.2 | GO:0015927 | trehalase activity(GO:0015927) |
0.2 | 0.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.2 | 0.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 1.7 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 0.7 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.2 | 0.6 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.2 | 1.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.2 | 3.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.2 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.2 | 0.5 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.2 | 1.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.2 | 2.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 0.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 3.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 1.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 2.8 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 0.9 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.2 | 7.3 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.2 | 1.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.3 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 1.0 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.2 | 2.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 1.7 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.2 | 0.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 0.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 1.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 0.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 0.5 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.2 | 0.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 0.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 0.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
0.1 | 0.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 1.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 3.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 1.9 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 3.6 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 1.2 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 0.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 19.4 | GO:0003729 | mRNA binding(GO:0003729) |
0.1 | 1.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.1 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.1 | 0.8 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.4 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 3.3 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.1 | 1.5 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.4 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 1.0 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 1.5 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 2.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.7 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 1.4 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 1.7 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.2 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.1 | 4.8 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.1 | 0.2 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.6 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.6 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.3 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 11.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 2.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 1.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 1.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 1.0 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.3 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 0.4 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.2 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.1 | 0.3 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 2.4 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 1.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 1.0 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 1.0 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.8 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 11.2 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 37.8 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 1.7 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 0.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.1 | GO:0070697 | activin receptor binding(GO:0070697) |
0.1 | 0.6 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.3 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 1.1 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 2.3 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.1 | 0.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.1 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.1 | 0.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 62.6 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.1 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.2 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.1 | 0.2 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 2.0 | GO:0043826 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.1 | 4.0 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.3 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.1 | 0.4 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.2 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 0.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 0.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 1.6 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.8 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.1 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.9 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.0 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.3 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 0.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.8 | GO:0046332 | SMAD binding(GO:0046332) |
0.0 | 0.8 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.1 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.0 | 0.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.2 | GO:0046977 | TAP binding(GO:0046977) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.4 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.0 | 0.0 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.0 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.0 | 0.0 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.4 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 30.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.9 | 12.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.8 | 13.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.8 | 20.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.6 | 9.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.5 | 7.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.5 | 6.6 | PID REELIN PATHWAY | Reelin signaling pathway |
0.5 | 9.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.4 | 21.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.4 | 9.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 10.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.4 | 14.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.4 | 6.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.4 | 5.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 11.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.4 | 16.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.4 | 6.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 14.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 1.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 0.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 6.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 13.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.3 | 7.6 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 5.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 0.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 0.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 1.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 0.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 2.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 24.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 2.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 2.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 2.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 2.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 8.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 3.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 9.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
2.0 | 33.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.8 | 20.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
1.8 | 27.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.6 | 22.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.6 | 4.7 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.4 | 28.9 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
1.4 | 12.7 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
1.2 | 13.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.1 | 29.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.0 | 14.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.9 | 10.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.9 | 16.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.9 | 4.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.9 | 0.9 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.8 | 32.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.8 | 34.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.8 | 9.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.8 | 18.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.7 | 13.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.7 | 10.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.6 | 0.6 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.6 | 6.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.6 | 4.7 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.6 | 13.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.6 | 10.9 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.6 | 8.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.5 | 1.6 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.5 | 10.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.5 | 2.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.5 | 35.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.5 | 3.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.5 | 5.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.5 | 10.1 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.5 | 0.5 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.4 | 1.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.4 | 3.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 3.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.4 | 0.8 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.4 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.4 | 5.2 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.3 | 1.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.3 | 2.1 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.3 | 3.4 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.3 | 3.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.3 | 6.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 2.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.3 | 0.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 0.9 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.3 | 44.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.3 | 3.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.3 | 3.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 3.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 2.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.3 | 6.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.3 | 2.7 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.3 | 12.5 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.3 | 5.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 4.7 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 2.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 1.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 2.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 4.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.2 | 2.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 1.7 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 3.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 3.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 2.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 1.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.6 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 0.3 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 1.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 2.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 2.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 4.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.8 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 0.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 3.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 2.3 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 0.2 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 0.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.7 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 1.0 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 0.8 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 0.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 1.1 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.1 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.0 | 0.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.0 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.0 | 0.5 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.0 | 0.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.4 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |